I agree that this site is using cookies. You can find further informations here.
X
Agostara, A.G.
21  results:
Search for persons X
?
1

Activity of osimeRTInib in non-small-cell lung Cancer with ..:

Pizzutilo, E.G. ; Agostara, A.G. ; Oresti, S....
ESMO Open.  9 (2024)  6 - p. 103592 , 2024
Link: https://doi.org/10.1016/..
 
?
2

72P Molecular characterization of advanced primary cardiac ..:

Agostara, A.G. ; Patelli, G. ; Bencardino, K....
ESMO Open.  8 (2023)  1 - p. 101109 , 2023
Link: https://doi.org/10.1016/..
 
?
3

EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon ..:

Pizzutilo, E.G. ; Agostara, A.G. ; Oresti, S....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S418-S419 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Different Role of Lipid Peroxidation in Oxidative Stress-In..:

Palozza, P. ; Agostara, G. ; Piccioni, E..
Archives of Biochemistry and Biophysics.  312 (1994)  1 - p. 88-94 , 1994
Link: https://doi.org/10.1006/..
 
?
5

Different Mechanisms of tert-Butyl Hydroperoxide-Induced Le..:

Bartoli, G.M. ; Piccioni, E. ; Agostara, G...
Archives of Biochemistry and Biophysics.  312 (1994)  1 - p. 81-87 , 1994
Link: https://doi.org/10.1006/..
 
?
6

Immune Checkpoint Inhibitors and the Exposome: Host-Extrins..:

Pizzutilo, Elio Gregory ; Romanò, Rebecca ; Roazzi, Laura...
Cancer Research.  83 (2023)  14 - p. 2283-2296 , 2023
Link: https://doi.org/10.1158/..
 
?
7

Activity of OsimeRTInib in NSCLC with UNcommon EGFR Mutatio..:

E. G. Pizzutilo ; G. Cerea ; S. Oresti...
ESMO.  , 2022
Link: https://hdl.handle.net/2..
 
?
8

Folfiri versus xeliri in untreated advanced colorectal canc..:

Giuliani, F. ; De Vita, F. ; Maiello, E....
European Journal of Cancer Supplements.  6 (2008)  14 - p. 120-121 , 2008
Link: https://doi.org/10.1016/..
 
?
9

3546 POSTER (XELOX)Capecitabine plus Oxaliplatin: clinical ..:

Alu', M. ; Laudani, A. ; Leonardi, V....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 273 , 2007
Link: https://doi.org/10.1016/..
 
?
10

Ligand Binding and Cytochemical Analysis of Estrogen and Pr..:

CASTAGNETTA, L. ; TRAINA, A. ; AGOSTARA, B....
Annals of the New York Academy of Sciences.  963 (2002)  1 - p. 98-103 , 2002
Link: https://doi.org/10.1111/..
 
?
11

New Approaches to Breast Cancer: Oxaliplatin Combined with ..:

LEONARDI, V. ; SAVIO, G. ; LAUDANI, A...
Annals of the New York Academy of Sciences.  963 (2002)  1 - p. 91-97 , 2002
Link: https://doi.org/10.1111/..
 
?
12

Gemcitabine plus vinorelbine in stage IIIB or IV non-small ..:

Palmeri, S. ; Leonardi, V. ; Gebbia, V....
Lung Cancer.  34 (2001)  1 - p. 115-123 , 2001
Link: https://doi.org/10.1016/..
 
?
13

Randomized phase III trial of the Southern Italy Oncology G..:

Gebbia, V ; Galetta, D ; Caruso, M...
Lung Cancer.  29 (2000)  1 - p. 27 , 2000
Link: https://doi.org/10.1016/..
 
?
14

Effectiveness of antiemetic drugs in prevention of chemothe..:

De Angelis, V. ; Ciccarese,, G. ; Alessandroni, P....
European Journal of Cancer.  33 (1997)  - p. S17 , 1997
Link: https://doi.org/10.1016/..
 
?
15

A multicentric phase II study with l-folinic acid (FA), flu..:

Colucci, G. ; Giotta, F. ; Gebbia, V....
European Journal of Cancer.  30 (1994)  - p. S24 , 1994
Link: https://doi.org/10.1016/..
 
1-15